Pine Labs Share Price Jumps 4% on 17 June 2026 as Citi Sets Rs 235 Buy Target and UBS Initiates With Rs 250 Buy Rating on Strong Growth Outlook

Pine Labs share price climbed to an intraday high of Rs 156.60 on 17 June 2026, a gain of approximately 4.34% from the previous close of Rs 150.09, as multiple global brokerages reinforced bullish coverage on the fintech merchant commerce platform. Citi maintained a Buy rating on Pine Labs share price with a target of Rs 235, projecting adjusted EBITDA and EBIT growth of 42% and 84% respectively over FY26-FY28 driven by affordability solutions, enterprise deal wins and rising monetisation across the commerce infrastructure ecosystem. UBS initiated coverage with a Buy rating and a target of Rs 250, calling Pine Labs a large-enterprise franchise with a durable moat and saying the stock’s 45% valuation discount to Paytm looks unjustified given Pine Labs’ stronger profitability. Morgan Stanley also maintains an Overweight rating at Rs 186. Pine Labs share price is currently trading approximately 31% below its IPO price of Rs 221 from November 2025, and brokerages are building the case that the gap between current price and fundamental value is now significant enough to accumulate.

Click Here – Get Free Investment Predictions

Pine Labs Brokerage Ratings: What Citi, UBS and Others Say

Pine Labs share price has attracted a strong brokerage consensus despite the stock’s underperformance since its November 2025 IPO. Brokerages are converging on a view that Pine Labs’ shift from device-led POS growth to value-added services, EMI affordability and agentic payments creates a more durable and higher-margin revenue stream over the medium term.

Brokerage	Rating	Target Price (Rs)	Implied Upside from Rs 153	Key Thesis
Citi	Buy	235	~54%	20%+ revenue growth; EBITDA CAGR 42% FY26-FY28; affordability business key driver
UBS	Buy	250	~63%	Durable moat; 20% revenue CAGR; 45% discount to Paytm unjustified given higher profitability
Morgan Stanley	Overweight	186	~22%	Large and growing TAM; 17% revenue CAGR; shift to value-added services
Jefferies	Buy	185	~21%	Revenue grew 17% in FY26; FY27 guidance 21-23% growth; core POS business stabilising
PINELABS on Univest	View live data	Track Pine Labs share price	–	Check latest fundamentals and technicals on Univest

Why Pine Labs Share Price Is Below Its IPO Price Despite Bullish Brokerages

Pine Labs share price listed at Rs 221 in November 2025 and has since declined approximately 31% to Rs 153.12. The IPO period coincided with a period of elevated expectations for high-growth fintech stocks. Post-listing, the stock re-rated lower as Q4 FY26 results showed revenue growing 17% year-on-year, broadly in line but not ahead of expectations, and with some weakness in the gift cards segment. Institutional selling pressure added to the downtrend, with Invesco Developing Markets Fund selling 7.9 million Pine Labs shares at Rs 145.97 per share in a recent transaction.

However, Pine Labs share price has delivered its first full-year profit in FY26, with PAT of Rs 113 crore versus a loss of Rs 145 crore in FY25. Q4 FY26 standalone PAT grew 305% year-on-year. Management has guided for 21-23.5% revenue growth in FY27. Pine Labs also launched P3P, India’s first agentic UPI payment protocol, in production on June 11, 2026, and completed the acquisition of Shopflo Technologies on June 10, strengthening its checkout and conversion capabilities. These developments form the basis for UBS’s and Citi’s bullish stance on Pine Labs share price.

Pine Labs Share Price Data on 17 June 2026

Metric	Value
NSE Symbol	PINELABS
CMP (17 Jun 2026)	Rs 153.12
Day High	Rs 156.60 (+4.34%)
Day Low	Rs 151.25
Previous Close	Rs 150.09
52-Week High	~Rs 284
52-Week Low	~Rs 111
IPO Price (Nov 2025)	Rs 221 (currently ~31% below IPO price)
Market Cap	~Rs 17,500 Cr
FY26 Revenue Growth	~17% YoY
FY26 PAT	Rs 113 Cr (first annual profit; vs loss of Rs 145 Cr in FY25)
FY27 Revenue Guidance	21-23.5% growth

Use the Univest Screener to compare Pine Labs share price with Paytm and fintech sector peers

Key Risks to Pine Labs Share Price

1. Trading Below IPO Price

Pine Labs share price at Rs 153 is approximately 31% below its November 2025 IPO price of Rs 221. This creates an overhang from investors who bought at IPO and are sitting on losses, potentially selling into any meaningful recovery. The stock also has a trailing price that reflects investor disappointment relative to IPO expectations.

2. Gift Cards Segment Weakness

Citi noted near-term weakness in Pine Labs’ gift cards and prepaid solutions segment. While Citi expects affordability solutions to offset this, any prolonged slowdown in the high-margin gifts and rewards business could weigh on overall EBITDA margin expansion, a key pillar of the bullish investment thesis for Pine Labs share price.

3. Competitive Pressure in Payments

Pine Labs competes against established fintech players including Paytm, Razorpay and PhonePe in the payments and merchant acquiring space. New entrants backed by deep pockets could undercut Pine Labs on pricing for POS deployment and transaction fees, compressing revenue growth below the 21-23.5% FY27 guidance that supports current Pine Labs share price targets.

4. RBI Compliance Risk

Pine Labs received a tax demand and faces ongoing regulatory scrutiny as an RBI-regulated payment infrastructure provider. Prepaid payment instrument (PPI) regulations can change, affecting Pine Labs’ affordability and gifting business. Any adverse regulatory action could create a negative overhang on Pine Labs share price.

Download the Univest iOS App or Univest Android App to track Pine Labs share price live and get the latest fintech sector stock recommendations.

Conclusion

Pine Labs share price gained approximately 4% to an intraday high of Rs 156.60 on 17 June 2026 as Citi (Buy, Rs 235), UBS (Buy, Rs 250) and Morgan Stanley (Overweight, Rs 186) reinforced their bullish stances on the fintech commerce platform. The brokerages converge on a view that Pine Labs’ first annual profit, 21-23.5% FY27 revenue guidance, durable enterprise moat and shift to value-added services like affordability solutions and agentic UPI justify a significant re-rating from the current price. Pine Labs share price at Rs 153 offers implied upside of 22-63% to the range of analyst targets, making it one of the most-watched small-mid cap fintech stocks for long-term investors. Key risks include the post-IPO downtrend, gift card segment weakness and competitive pressure in merchant payments.

Frequently Asked Questions on Pine Labs Share Price

Why is Pine Labs share price rising today?

Ans. Pine Labs share price gained approximately 4% to an intraday high of Rs 156.60 on 17 June 2026 after multiple brokerages maintained or initiated bullish ratings on the fintech stock. Citi maintained a Buy rating with a target of Rs 235, while UBS initiated coverage with a Buy rating and a target of Rs 250. Morgan Stanley maintains an Overweight rating at Rs 186. The brokerage consensus reflects confidence in Pine Labs’ revenue growth guidance of 21-23.5% for FY27.

What is UBS’s view on Pine Labs share price?

Ans. UBS initiated coverage on Pine Labs with a Buy rating and a target price of Rs 250, implying approximately 43% upside from the stock’s last close before initiation. UBS said Pine Labs maintains a strong large-enterprise franchise with a durable moat driven by scale and deep integration with banks, original equipment manufacturers and merchants. The brokerage expects revenue to sustain at approximately 20% CAGR over FY2026-FY2028 and said the current 45% valuation discount to Paytm looks unjustified given Pine Labs’ stronger profitability.

What is Citi’s view on Pine Labs share price?

Ans. Citi maintained a Buy rating on Pine Labs share price with a target of Rs 235, implying approximately 62% upside from its price around Rs 144-146 at the time of the note. Citi said Pine Labs’ guidance implies more than 20% revenue growth along with continued EBITDA margin expansion over the next few years. The brokerage projects adjusted EBITDA and EBIT growth of 42% and 84% respectively over FY26-FY28, citing rising affordability solutions adoption and enterprise deal wins as key growth drivers.

What is Pine Labs share price today on 17 June 2026?

Ans. Pine Labs share price (NSE: PINELABS) is Rs 153.12 as of 17 June 2026, touching an intraday high of Rs 156.60 against a previous close of Rs 150.09. The 52-week high is approximately Rs 284 and the 52-week low is approximately Rs 111. Pine Labs was listed in November 2025 at an IPO price of Rs 221 and is currently trading approximately 31% below its issue price.

What is Pine Labs’ business model?

Ans. Pine Labs is a merchant commerce platform that provides digital payments, point-of-sale (POS) infrastructure, buy-now-pay-later and EMI affordability solutions, and issuing solutions for merchants, consumer brands and enterprises. The company operates across India and Southeast Asia, serving large enterprise clients through deep integration with banks, OEMs and merchant networks. It acquired Shopflo Technologies on June 10, 2026, adding checkout and conversion capabilities to its platform.

What was Pine Labs’ financial performance in FY26?

Ans. Pine Labs posted its first annual profit in FY26, with PAT of Rs 113 crore, reversing a loss of Rs 145 crore in FY25. Q4 FY26 PAT was Rs 59.36 crore, up 305.33% year-on-year. FY26 revenue growth was approximately 17% year-on-year. The company has also launched P3P, India’s first agentic UPI payment protocol, in production on June 11, 2026, which could open new revenue opportunities in AI-driven commerce.

What are the key risks to Pine Labs share price?

Ans. Key risks to Pine Labs share price include the stock trading 31% below its IPO price of Rs 221, competition from established payment players like Paytm and Razorpay, near-term weakness in the gift cards segment flagged by Citi, RBI compliance risk (Pine Labs received a tax demand of Rs 373 million in early 2026), and the Invesco Developing Markets Fund’s recent sale of 7.9 million shares at Rs 145.97 per share, which created some selling pressure.

What should investors watch for Pine Labs share price?

Ans. Investors tracking Pine Labs share price should monitor quarterly revenue growth versus the 21-23.5% FY27 guidance, EBITDA margin expansion trajectory, adoption of the new agentic UPI protocol, progress of the Shopflo integration, and any further brokerage initiations or target upgrades. The Rs 235 Citi target and Rs 250 UBS target provide a 54-63% upside range from the current price. Consult a SEBI-registered financial advisor before investing.